COAGULATION ABNORMALITIES IN CHRONIC PERITONEAL-DIALYSIS

被引：28

作者：

JONES, CL ^{[1
]}

ANDREW, M ^{[1
]}

EDDY, A ^{[1
]}

ONEIL, M ^{[1
]}

SHALOM, NI ^{[1
]}

BALFE, JW ^{[1
]}

机构：

[1] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT NEPHROL,TORONTO M5G 1X8,ONTARIO,CANADA

来源：

PEDIATRIC NEPHROLOGY | 1990年 / 4卷 / 02期

关键词：

Coagulation; Hypercoagulability; Peritoneal dialysis;

D O I：

10.1007/BF00858827

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

To determine whether children treated with chronic peritoneal dialysis have a hypercoagulable state, various coagulation and fibrinolytic factor concentrations or activities were measured in 17 children undergoing chronic peritoneal dialysis. The patients had significantly increased activities of factors VII and VIII and increased concentrations of von Willebrand factor (vWF), fibrinogen, factor XIIIA and factor XIIIS compared to reference values (P<0.001 in each case). The activated partial thromboplastin time was prolonged (P<0.001) and the thrombin clotting time was decreased (P<0.05) in these children. The prothrombin time and activities of factors XII, XI, IX, X, V and II were not significantly different from control values. Protein C concentrations were similar to normal, but antithrombin III concentrations were increased (P<0.05). Within the fibrinolytic pathway, decreased concentrations of plasminogen were found (P<0.001) and the concentrations of alpha-2-antiplasmin were increased (P<0.001). The plasma albumin concentration was below 33 g/l in 13 of the 17 children. The duration of treatment with peritoneal dialysis was directly correlated with vWF concentrations (P<0.001) and inversely correlated with factor VII concentrations (P<0.01). Of these patients 2 have since had clinical thrombotic episodes. The coagulation abnormalities found may have a role in the occurrence of thrombosis complicating renal transplantation. © 1990 IPNA.

引用

页码：152 / 155

页数：4

共 18 条

[1]

Bertoli M., Gasparotto M.L., Vertolli U., Ruffatti A., DiLandro D., Romagnoli G.F., Does hypercoagulability exist in CAPD patients?, Perit Dial Bull, 4, pp. 237-239, (1984)

[2]

Andrew M., Paes B., Johnston M., Mitchell L., Tollefsen D.M., Powers P., Development of the human coagulation system in the fullterm infant, Blood, 70, pp. 165-172, (1987)

[3]

Schrader J., Scheler F., Blood coagulation studies in CAPD and treatment with low molecular weight heparin intraperitoneally (abstract), Perit Dial Bull, 6, (1986)

[4]

DeStefano V., Triolo L., DeMartini D., Ferrelli R., Mori R., Leone G., Antithrombin III loss in patients with nephrotic syndrome or receiving continous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome, J Lab Clin Med, 109, pp. 550-555, (1987)

[5]

Zimmerman S., Chronic peritoneal dialysis is associated with progressive thrombocytosis, Perit Dial Bull, 6, pp. 71-73, (1986)

[6]

Anagnostou A., Kurtzman N.A., Haematological consequences of renal failure, chapter 38, The kidney, (1986)

[7]

Remuzzi G., Pusineri F., Coagulation defects in uraemia, Kidney Int, 31, pp. S13-S17, (1987)

[8]

Yoshioka K., Miyata H., Uraoka Y., Maki S., Plasma factor XIII levels in children with renal disease, Nephron, 27, pp. 10-13, (1981)

[9]

Woods H.F., Dawson A., Ash G., Weston M., Heparin induced decrease in circulating antithrombin III, Lancet, 1, pp. 209-211, (1978)

[10]

Searcy R.M., Malagelada J.R., Ménétrier's disease and idiopathic hypertrophic gastropathy, Ann Intern Med, 100, pp. 565-570, (1984)

← 1 2 →